Takeda Pharmaceutical Co., Ltd.
(NYSE : TAK)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.68%145.650.7%$932.14m
PFEPfizer Inc. 0.84%36.060.9%$892.16m
MRKMerck & Co., Inc. -0.24%82.950.7%$692.55m
ABBVAbbVie, Inc. 0.35%86.211.9%$677.02m
BMYBristol-Myers Squibb Co. 2.15%59.501.0%$637.89m
LLYEli Lilly & Co. 0.97%150.261.1%$561.78m
AZNAstraZeneca Plc 2.47%55.511.2%$257.73m
NVSNovartis AG 0.96%87.130.2%$163.92m
GSKGlaxoSmithKline Plc 1.12%37.800.2%$109.18m
PRNBPrincipia Biopharma, Inc. 0.10%100.050.0%$86.76m
NVONovo Nordisk A/S 1.13%69.040.1%$57.64m
RGENRepligen Corp. 3.12%144.307.1%$49.54m
SNYSanofi -0.02%50.780.2%$49.00m
RPRXRoyalty Pharma Plc -0.40%40.070.2%$47.01m
OPKOPKO Health, Inc. 4.89%3.2211.2%$43.56m

Company Profile

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.